ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 12.00
-0.40 (-3.23%)
At close: Mar 4, 2026
ViroGates Market Cap
ViroGates has a market cap or net worth of 111.38 million as of March 5, 2026. Its market cap has increased by 24.14% in one year.
Market Cap
111.38M
Enterprise Value
107.04M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.00
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 111.38M, a decrease of -57.03%. That is a compound annual growth rate of -10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 111.38M | -10.78% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.10T |
| Genmab | 109.14B |
| Coloplast | 103.96B |
| ALK-Abelló | 49.85B |
| BioPorto | 465.89M |
| Pharma Equity Group | 113.43M |
| Scandinavian Medical Solutions | 89.54M |
| Stenocare | 58.10M |